Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label two-period mass balance and pharmacokinetic study of 14C-GSK573719 in healthy male adults
NL-OMON36078Active, not recruiting
- Sponsor
- GSK
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of umeclidinium in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Primary endpoints: Radiokinetics, Pharmacokinetics and 2 more. Started Apr 2011; status: active, not recruiting.
02
Drugs
umeclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON36078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36078.